Search
for
Sort by
Research 151–180 of 346
- Reflections of COVID-19 Pandemic on Dermatology Outpatient Clinics
- Scaly Papular Lesions
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- The COVID-19 pandemic and its skin effects
- “PRIDE” Complex
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- Delayed hypersensitivity reaction to intralesional triamcinolone acetonide following treatment for alopecia areata. Intradermal testing.
- TONGUE, RED
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Bicalutamide: A review
- Skin Manifestations of Rheumatological Diseases
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Medical Dermatology
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases